| Variables |
FALSE |
TRUE |
p-Value |
| Number of Patients |
3538 |
1665 |
|
| Black –n (%) |
170 ( 4.8) |
106 ( 6.4) |
0.023 |
| Peripheral vascular disease –n(%) |
1195 ( 33.8) |
552 ( 33.2) |
0.68 |
| Dementia –n (%) |
286 ( 8.1) |
121 ( 7.3) |
0.333 |
| Pulmonary disease–n (%) |
2496 ( 70.5) |
1033 ( 62.0) |
<0.001 |
| Diabetes Mellitus –n (%) |
735 ( 20.8) |
393 ( 23.6) |
0.023 |
| Diabetes Mellitus with Complications–n (%) |
670 ( 18.9) |
310 (
18.6) |
0.813 |
| Cancer –n (%) |
552 ( 15.6) |
240 ( 14.4) |
0.284 |
| Liver-Severe –n (%) |
107 ( 3.0) |
34 ( 2.0) |
0.052 |
| Metastatic malignancy–n TRUE (%) |
226 ( 6.4) |
68 ( 4.1) |
0.001 |
| HIV –n (%) |
8 ( 0.2) |
7 ( 0.4) |
0.346 |
| Liver disease- Mild –n(%) |
436 ( 12.3) |
209 ( 12.6) |
0.85 |
| CHF –n(%) |
3538 (100.0) |
1665 (100.0) |
NA |
| HFpEF–n(%) |
2690 ( 76.0) |
0 ( 0.0) |
<0.001 |
| HFrEF –n (%) |
0 ( 0.0) |
1665 (100.0) |
<0.001 |
| Mixed HF –n(%) |
848 ( 24.0) |
0 ( 0.0) |
<0.001 |
| Ischemic heart disease—n(%) |
2209 ( 62.4) |
1351 ( 81.1) |
<0.001 |
| Valvular heart disease –n(%) |
2026 ( 57.3) |
1035 ( 62.2) |
0.001 |
| Cardiomyopathy –n (%) |
1036 ( 29.3) |
1238 ( 74.4) |
<0.001 |
| Maximum_NT-proBNP (median [IQR]) |
4865.00 [1750.00, 12002.75] |
4760.00 [1690.00, 11500.00] |
0.39 |
| Initial NT-proBNP (mean (sd)) |
4314.25 (6605.13) |
7993.94 (13108.46) |
<0.001 |
| Maximum creatinine (median [IQR]) |
1.49 [1.10, 2.14] |
1.50
[1.17, 2.17] |
0.014 |
| Maximum EF (%,mean (sd)) |
58.57 (5.76) |
31.20 (10.14) |
<0.001 |
| Minimum_EF (%,mean (sd)) |
50.64 (12.01) |
25.77 (10.24) |
<0.001 |
| Charlson Comorbidity Score (mean (sd)) |
4.81 (2.22) |
4.47 (2.05) |
<0.001 |
| Survival <6 months= TRUE(%) |
529 ( 15.0) |
262 ( 15.7) |
0.488 |
| Mean Weight(lbs) (mean(sd)) |
189.03 (60.25) |
188.23 (55.20) |
0.647 |